SEC Form 4 · accession 0001144204-18-062799
MUSTANG BIO, INC. · MBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian Achenbach
Officer — VP, Fin. & Corp. Controller
Period of report
Feb 2, 2018
Accepted (ET)
Dec 3, 2018 · 12:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001680048
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCKF1 | Feb 2, 2018 | A | 55,000 | $0.00 | A | 55,000 | D | |
| COMMON STOCKF2,F1 | Nov 16, 2018 | P | 1,000 | $4.31 | A | 56,000 | D | |
| COMMON STOCKF2,F1 | Nov 19, 2018 | P | 1,000 | $4.25 | A | 57,000 | D | |
| COMMON STOCKF1 | Nov 20, 2018 | P | 500 | $3.8742 | A | 57,500 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F155,000 shares are restricted Common Stock which vest over various time periods.
- F2Reflects the weighted average purchase price of multiple same-way open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the purchase transactions on November 16, 2018 was $4.15 to $4.3792, and the range of prices for the purchase transactions on November 19, 2018 was $4.15 to $4.35. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.